ALSA Ventures

ALSA Ventures is a venture capital firm established in 2019 and located in London, United Kingdom. The firm focuses on investing in biotechnology companies that are dedicated to developing innovative therapies for patients. ALSA Ventures targets businesses within the life sciences, pharmaceuticals, therapeutics, and biotechnology sectors, emphasizing its commitment to supporting advancements in healthcare through strategic investments.

Lorna Collings

CFO

Julia Jones

Investment Manager

Alek Safarian

CEO

Katie Sunnucks

Investment Director

3 past transactions

Jatri

Series A in 2023
Jatri is the fastest growing technology company in Bangladesh with a mission to bring reliable transport to everyone, everywhere at the touch of a button. We are offering a mobility-as-a-service platform that enhances bus system reliability and quality.

Epsilogen

Series B in 2022
IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.

Montis Biosciences

Seed Round in 2020
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.